Pharmaceuticals & Biotech U.S. Community
WA
Based on Analyst Price Targets
Jeff Hackman's Leadership And PEDMARK's Launch Promise Robust Revenue Surge
US$15.50
FV
66.5% undervalued intrinsic discount32.12%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
1 day agoauthor updated this narrative